The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 375-380

  Schimmel, Leyla ^a   Khandekar, Vrinda S ^a   Martin, Katherine J ^a   Riera, Thomas ^a   Honan, Christopher ^a   Shaw, David G ^a   Kaddurah Daouk, Rima ^a,b  

^a Amira Inc   (United States)

^b Avicena Group   (United States)

Author keywords

Creatine kinase; Cyclocreatine; Cyclocreatine phosphate; Xenograft tumor models

Indexed keywords

CREATINE KINASE; CREATINE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG POTENCY; DRUG SPECIFICITY; DRUG SYNTHESIS; DRUG UPTAKE; ENERGY METABOLISM; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; CELL DIVISION; CREATININE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMIDAZOLIDINES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; PHOSPHOCREATINE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029887763     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem 281: 21-40, 1992.
2. Bessman SP, Carpenter CL: The creatine-creatine phosphate energy shuttle. Ann Rev Biochem 54: 831-862, 1985.
3. Kaddurah-Daouk R, Lillie JW, Daouk GH, Green MR, Kingston R, Schimmel P: Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a. Mol Cell Biol 10: 1476-1483, 1990.
4. Lillie JW, O'Keefe M, Valinski H, Hamlin HA Jr, Varban ML, Kaddurah-Daouk R: Cyclocreatine(1-carboxymethyl-2 iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. Cancer Res 53: 3172-3178, 1993.
5. Martin KJ, Chen SF, Clark GM, Degen D, Wajima M, Von Hoff DD, Kaddurah-Daouk R: Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. J Natl Cancer Inst 86: 608-613, 1994.
6. Zhou J, Schmieg FI, Simmons DT and Molloy GR. Mouse p53 represses the rat brain creatine kinase gene, but activates the rat muscle creatine kinase gene. Mol Cell Biol 14: 8483-8492, 1994.
7. Carney DN, Zweig MH, Ihde DC, Cohen MH, Makuch RW, Gazdar AP: Elevated serum creatine kinase BB levels in patients with small cell lung cancer. Cancer Res 44: 5399-5403, 1984.
8. Ishiguro Y, Kato K, Akatsuka H, Ito T: The diagnostic and prognostic value of pretreatment serum creatine kinase BB levels in patients with neuroblastoma. Cancer 65: 2014-2019, 1990.
9. Feld RD, Witte DL: Presence of creatine kinase BB isoenzyme in some patients with prostatic carcinoma. Clin Chem 23: 1930-1932, 1977.
10. Rowley GL, Greenleaf AL, Kenyon GL: On the specificity of creatine kinase New glycocyamines and glycocyamine analogs related to creatine. J Am Chem Soc 93: 5542-5551, 1971.
11. Miller EE, Evans AE, Cohn M: Inhibition of rate of tumor growth by creatine and cyclocreatine. Proc Natl Acad Sci 90: 3304-3308, 1993.
12. Teicher BA, Menon K, Northey D, Liu J, Kufe DW, Kaddurah-Daouk R: Cyclocreatine in cancer chemotherapy. Cancer Chemoth Pharmacol 35. 411-416, 1995.
13. Martin KJ, Winslow ER, Kaddurah-Daouk R: Cell cycle studies of cyclocreatine, a new anti cancer agent. Cancer Res 54: 5160-5165, 1994.
14. Martin KJ, Vassallo CD, Teicher BA, Kaddurah-Daouk R: Microtubule stabilization and potentiation of taxol activity by the creatine analog cyclocreatine. Anti-Cancer Drugs 6: 419-426, 1995.
15. Annesley TM, Walker JB: Cyclocreatine phosphate as a substitute for creatine phosphate in vertebrate tissues. Biochem Biophys Res Commun 74: 185-190, 1977.
16. Annesley TM, Walker JB; Energy metabolism of skeletal muscle containing cyclocreatine phosphate. J Biol Chem 255: 3924-3930, 1980.
17. Griffiths GR, Walker JB: Accumulation of analog of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine). J Biol Chem 251: 2049-2054, 1976.
18. Rowley GL, Kenyon GL: PEI-cellulose thin-layer chromatography. Product studies of the creatine kinase and pyruvate kinase reactions. Anal Biochem 58: 525-529, 1974.
19. Preobrazhenskii AN, Dzhavatov SA, Saks VA: [Possible mechanism of the protective effect of phosphocreatine on the ischemic myocardium]. Biokhimiya 51: 675-683, 1986.
20. Down WH, Chasseaud LF, Ballard SA: The effect of intravenously administered phosphocreatine on ATP and phosphocreatine concentrations in the cardiac muscle of the rat. Drug Res (3)1: 552-554, 1983.